We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pinpointing Lung Cancer Genes

By Biotechdaily staff writers
Posted on 14 Jul 2005
Cancer researchers have used single nucleotide polymorphism (SNP) array technology to pinpoint the location of deletions and amplifications in genes involved in lung cancer.

Investigators at the Dana-Farber Cancer Institute (Boston, MA, USA; www.dfci.harvard.edu) analyzed about115,000 single nucleotide polymorphism loci from 70 primary human lung carcinoma specimens and 31 cell lines derived from human lung carcinomas. More...
In addition to previously characterized loci, two regions of homozygous deletion and three regions of high-level amplification were found. These results were published in the July 2005 issue of Cancer Research.

"In a previous study, we showed that SNP arrays offer a unique way of locating copy-number changes in cell chromosomes and of determining when genes on a pair of chromosomes are mismatched,” said senior author, Dr. Matthew Meyerson, professor of pathology at the Dana-Farber Cancer Institute. "The current study demonstrates that high-resolution SNP technology is powerful enough to identify copy-number alterations that previously had not been found in lung cancer cells. We will need to characterize the genes in these regions in detail to understand their role and whether they are cancer-causing or cancer-preventing genes.”





Related Links:
Dana-Farber Cancer Institute

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Total Laboratory Automation Solution
SATLARS Mini T8
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.